PIRS Bathi mangsa ngarep Pieris Pharmaceuticals Inc

Simbol resmi perusahaan Pieris Pharmaceuticals Inc (PIRS)

The search for strategic alliances with industry behemoths defines the development vector of Pieris Pharmaceuticals (PIRS). The company's forward earnings, as shown on this chart from GURU.Markets, demonstrate the impact of the cost of capital, where captures the current value of the indicator. Growth is based on the Anticalin platform and cost optimization, although geopolitical tensions and sanctions seriously hinder the international logistics of components.

pieris.com (PIRS): Bathi resik sing dikarepake saka 04.07.2022 nganti 17.11.2026

Pieris - rincian analitis lan metrik utama (PIRS)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:PIRS, Pieris Pharmaceuticals, Inc.
Produk dadi Pieris Pharmaceuticals Inc

Portfolio managers evaluate the operating model of Pieris Pharmaceuticals (PIRS) through the lens of long-term profitability. This metric identifies systemic business degradation or growth by measuring the expected return on invested capital. By analyzing the projected financial result, an investor determines the asset's real value without market illusions. For Pieris Pharmaceuticals, this forecast is based on the commercialization of stable anticalins for lung therapy. The trend in the projected financial result confirms the company's fundamental stability.

Analisis pesaing Pieris Pharmaceuticals

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik TNXP|Bathi sing dikarepake China SXT Pharmaceuticals, Inc.|EPRX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep BHST|EXOZ - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ORMP (oramed.com)|Proyeksi bathi mangsa ngarep enterabio.com ENTX|HYFT - Bathi sing dikarepake|Prakiraan bathi perusahaan ABVC BioPharma, Inc ABVC|CPIX: Proyeksi bathi mangsa ngarep|Quantum BioPharma Ltd - Penghasilan resik sing dikarepake|Bathi mangsa ngarep FGEN|Telomir Pharmaceuticals, Inc. - Bathi forward|Proyeksi bathi mangsa ngarep RANI|SNYR (Synergy CHC) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Rallybio RLYB|Lexaria Bioscience (LEXX) - Bathi resik sing dikarepake|PULM - Bathi sing dikarepake|Prakiraan bathi perusahaan Pheton Holdings PTHL|APM (Aptorum) - Bathi mangsa ngarep|Lyra Therapeutics, Inc. (LYRA) - Proyeksi bathi mangsa ngarep|IBO (impactbiomedinc.com) - Proyeksi bathi mangsa ngarep|TNFA (TNF Pharmaceuticals) - Bathi resik mangsa ngarep|Bathi sing dikarepake cbdmd.com (YCBD)|Prakiraan bathi perusahaan PainReform Ltd|Proyeksi bathi mangsa ngarep CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Bathi resik sing dikarepake|OPTN - Bathi sing dikarepake|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan